Work

Letter Concerning Comparative Safety Profiles of Ocrelizumab and Rituximab in MS Treatment

Year: 2025

Type: article

Source: Annals of Neurology

DOI: 10.1002/ana.78137

Authors: Anders Svenningsson, Fredrik Piehl, Annette M. Langer‐Gould

Institutions: Danderyds sjukhus, Karolinska Institutet, Karolinska University Hospital, Los Angeles Medical Center, Kaiser Permanente Bernard J. Tyson School of Medicine

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W7117548733

FWCI: 1.777

Cites: 4

Cited by: 3

Related to: